BUMEX Trademark

Trademark Overview

On Tuesday, July 13, 2021, a trademark application was filed for BUMEX with the United States Patent and Trademark Office. The USPTO has given the BUMEX trademark a serial number of 90825344. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, June 11, 2025. This trademark is owned by Validus Pharmaceuticals LLC. The BUMEX trademark is filed in the Pharmaceutical Products category with the following description:

Diuretic preparation sold only on prescription
bumex

General Information

Serial Number90825344
Word MarkBUMEX
Filing DateTuesday, July 13, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, June 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2022

Trademark Statements

Goods and ServicesDiuretic preparation sold only on prescription

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameValidus Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameValidus Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Friday, July 16, 2021NEW APPLICATION ENTERED
Friday, September 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 3, 2022ASSIGNED TO EXAMINER
Monday, February 7, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, February 7, 2022EXAMINERS AMENDMENT E-MAILED
Monday, February 7, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 7, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, March 15, 2022PUBLISHED FOR OPPOSITION
Monday, April 11, 2022OPPOSITION PAPERS RECEIVED AT TTAB
Monday, April 11, 2022OPPOSITION INSTITUTED NO. 999999
Tuesday, April 30, 2024OPPOSITION DISMISSED NO. 999999
Tuesday, April 30, 2024TTAB RELEASE CASE TO TRADEMARKS
Monday, February 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2024OPPOSITION TERMINATED NO. 999999
Tuesday, June 11, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 10, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 10, 2024SOU EXTENSION 1 FILED
Tuesday, December 10, 2024SOU EXTENSION 1 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 11, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, June 11, 2025SOU EXTENSION 2 FILED
Wednesday, June 11, 2025SOU EXTENSION 2 GRANTED
Monday, September 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

bumex prescription only sold preparation diuretic